市場調查報告書

配藥全球市場:治療領域,產品,應用,製劑類型,無菌,按分銷渠道進行的行業分析,按地區進行的行業分析,區域展望,增長潛力,價格趨勢,競爭性市場佔有率和未來預測(2020-2026年) )

Compounding Pharmacies Market Size By Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel, Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2026

出版商 Global Market Insights Inc. 商品編碼 942665
出版日期 內容資訊 英文 348 Pages
商品交期: 2-3個工作天內
價格
配藥全球市場:治療領域,產品,應用,製劑類型,無菌,按分銷渠道進行的行業分析,按地區進行的行業分析,區域展望,增長潛力,價格趨勢,競爭性市場佔有率和未來預測(2020-2026年) ) Compounding Pharmacies Market Size By Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel, Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2026
出版日期: 2020年06月05日內容資訊: 英文 348 Pages
簡介

隨著患者對定製藥物和可幫助治療多種疾病的藥物的需求不斷增長,預計配藥藥房市場將在未來幾年內記錄增長。配藥藥房通常生產定製藥品和非上市或非上市藥品。這些藥房可以給與其他形式的藥物,藥物劑量,無糖藥物等。

按治療領域,產品,用途,分配類型,無菌性和分配渠道細分了分配藥房市場。

根據治療領域,藥房市場分為膳食補充劑,特種藥物,皮膚病學應用,疼痛管理,替代激素等。

2019年,膳食補充劑市場價值超過5.8億美元。膳食補充劑是旨在提供營養的膳食補充劑,包括蛋白質,礦物質,氨基酸,維生素和其他營養物質。這些產品通常以片劑,膠囊或液體的形式服用。

就產品而言,藥房市場分為耳,眼,鼻,腸胃外,直腸,局部和口服。鼻產品部門在2019年獲得了大約8%的市場份額。鼻腔給藥是通過鼻腔注射藥物的給藥途徑。

鼻腔輸送有助於解決與藥物降解,胃腸道不良事件,吸收延遲,生物利用度降低有關的問題,並避免肝臟中的首度通過代謝。

在應用方面,配藥市場分為獸醫,老年人,成人和兒童。到分析階段結束時,老年應用細分市場可能會記錄約6.5%的CAGR。陪伴動物數量的急劇增加將推動動物群體的增長。

按藥物類型劃分的市場分為藥物劑量變化(PDA),當前不可用的藥物生產(CUPM),藥物成分變化(PIA)等。

2019年,CUPM領域的市場價值超過22億美元。藥品短缺的原因有很多,包括質量問題,由於使用減少和製造商利潤減少而導致的停藥和延誤。它還可能影響新藥的發佈。

關於無菌,藥房市場分為非無菌和無菌劑型。在預期的時期內,無菌劑型將以大約6.5%的CAGR增長。隨著慢性疾病的發生率增加,對無菌藥物的需求預計會增加。

根據分銷渠道,配藥藥房市場分為配藥藥房,醫院藥房等。其他細分市場在2019年的市場價值超過8.5億美元,並有望繼續大幅增長。

該報告調查了全球製藥市場,並總結了市場概況,細分市場趨勢,地區趨勢以及進入市場的主要公司的概況。

內容

第1章調查方法

  • 調查方法
  • 市場定義
  • 預測參數
  • 數據源
    • 次要
    • 主要

第2章執行摘要

  • 配藥行業概覽,2015-2026年
    • 業務趨勢
    • 治療領域的趨勢
    • 產品趨勢
    • 應用趨勢
    • 複合類型趨勢
    • 不孕趨勢
    • 分銷渠道趨勢
    • 區域趨勢

第3章配藥行業的考慮因素

  • 行業細分
  • 2015-2026年行業情勢
  • 工業生態系統分析
    • 分銷渠道分析
  • 對行業的影響
    • 成長要因
    • 行業陷阱和挑戰
  • 增長潛力分析
    • 按治療領域
    • 按產品
    • 通過申請
    • 按配方類型
    • 無菌
    • 通過分銷渠道
  • 法規狀態
    • 美國
    • 歐洲
    • 澳大利亞
  • 報銷情況
    • 美國
    • 歐洲
    • 澳大利亞
  • 聯合用藥成本分析
  • 2019年按地區劃分的配藥店數量
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲
  • 創新的混合技□□術
    • 基於Web的質量控制系統
    • 數字工具
  • 波特分析
  • PESTEL分析

第4章按治療領域劃分的市場

  • 主要細分趨勢
  • 激素補充
    • 區域激素替代市場,2015-2026年,(百萬美元)
  • 疼痛管理
    • 區域疼痛管理市場,2015-2026年,(百萬美元)
  • 皮膚科醫生
    • 按地區分列的皮膚科市場,2015-2026年(百萬美元)
  • 特種醫學
    • 按地區劃分的特種藥物市場,2015-2026年(百萬美元)
  • 膳食補充劑
    • 按地區分列的營養補充劑市場,2015-2026年(百萬美元)
  • 其他
    • 按地區分列的其他市場,2015-2026年,(百萬美元)

第5章按產品分配藥房市場

  • 主要細分趨勢 口語
    • 按地區劃分的經口製劑市場,2015-2026年(百萬美元)
    • 固體製劑
    • 液體製劑
  • 本地
    • 2015-2026年按地區分列的當地市場,(百萬美元)
    • 藥膏
    • 乳霜
    • 凝膠
    • 粘貼
    • 其他
  • 直腸
    • 2015-2026年按區域劃分的直腸市場(百萬美元)
    • 栓劑
    • 灌腸
    • 其他
  • 腸胃外
    • 2015-2026年按地區劃分的腸胃外市場(百萬美元)
    • 小腸外(SVP)解決方案
    • 大劑量腸胃外(LVP)解決方案
  • 鼻子
    • 區域鼻子市場,2015-2026年(百萬美元)
  • 眼科
    • 按區域分列的眼科市場,2015-2026年(百萬美元)
  • 耳鼻喉科
    • 2015-2026年各地區的槳葉市場(百萬美元)

第6章通過應用分配藥房市場

  • 主要細分趨勢
  • 兒科
    • 按地區分列的小兒配藥市場(2015-2026年,百萬美元)
  • 成人
    • 按地區劃分的成人配藥市場(2015-2026年,百萬美元)
  • 老年病
    • 老年藥市場,按地區,2015-2026(百萬美元)
  • 獸醫
    • 按地區劃分的獸藥批發市場(2015-2026年,百萬美元)

第7章配藥類型的配藥市場

  • 主要細分趨勢
  • 藥物成分變更(PIA)
    • 按地區分列的藥物成分變化(PIA)市場,2015-2026年,(百萬美元)
  • 當前無法使用的藥品製造(CUPM)
    • 當前不可用的藥品製造(CUPM)市場,按地區分列,2015-2026,(百萬美元)
  • 更改藥物劑量(PDA)
    • 按地區分列的藥物劑量變化(PDA)市場,2015-2026年,(百萬美元)
  • 其他
    • 按地區分列的其他市場,2015-2026年,(百萬美元)

第8章無菌配藥市場

  • 主要細分趨勢
  • 不育
    • 按地區分列的無菌點膠藥市場,2015-2026年(百萬美元)
  • 非無菌
    • 按地區劃分的非處方藥房市場,2015-2026年(百萬美元)

第9章通過分銷渠道分配藥房市場

  • 主要細分趨勢
  • 醫院藥房
    • 按地區分列的醫院藥房市場,2015-2026年(百萬美元)
  • 配藥
    • 按地區劃分的藥房市場,2015-2026年,(百萬美元)
  • 其他
    • 按地區分列的其他市場,2015-2026年,(百萬美元)

第10章按地區調劑藥局市場

  • 區域趨勢
  • 北美
    • 2015-2026年按國家分列的北美調劑藥局市場(百萬美元)
    • 2015-2026年按治療領域劃分的北美調劑藥局市場(百萬美元)
    • 2015-2026年北美調劑藥局式場的產品分佈(百萬美元)
    • 北美調劑藥局市場,按應用分列,2015-2026年(百萬美元)
    • 2015-2026年北美調劑藥局市場(按點膠類型)(百萬美元)
    • 北美調劑藥局市場,按無菌分列,2015-2026年(百萬美元)
    • 2015-2026年北美經銷渠道的調劑藥局市場(百萬美元)
    • 美國
    • 按應用劃分的美國調劑藥局市場,2015-2026年(百萬美元)
    • 2015-2026年美國調劑藥局市場(按點膠類型)(百萬美元)
    • 2015年至2026年按無菌分列的美國調劑藥局市場(百萬美元)
    • 按分銷渠道劃分的美國調劑藥局市場,2015-2026年(百萬美元)
    • 加拿大
    • 按應用分列的加拿大調劑藥局市場,2015-2026年(百萬美元)
    • 2015-2026年加拿大調劑藥局市場(按點膠類型)(百萬美元)
    • 按無菌分列的加拿大調劑藥局市場,2015-2026年(百萬美元)
    • 2015-2026年加拿大經銷渠道的調劑藥局市場(百萬美元)
  • 歐洲
    • 2015-2026年歐洲按地區分藥市場(百萬美元)
    • 按治療領域劃分的歐洲點膠藥市場,2015-2026年(百萬美元)
    • 歐洲點膠藥市場的產品分佈,2015-2026年(百萬美元)
    • 按應用分列的歐洲點膠藥市場,2015-2026年(百萬美元)
    • 歐洲點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 歐洲不丹配藥市場,按無菌分列,2015-2026年(百萬美元)
    • 按分銷渠道劃分的歐洲製藥市場,2015-2026年(百萬美元)
    • 德國
    • 按應用分列的德國點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年按藥房類型劃分的德國藥房市場(百萬美元)
    • 德國無菌藥房市場,2015-2026年(百萬美元)
    • 2015-2026年全球經銷渠道的德國配藥市場(百萬美元)
    • 英國
    • 按應用分列的英國點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年英國點膠藥房市場(按點膠類型)(百萬美元)
    • 英國點膠藥房市場,按無菌度分,2015-2026(百萬美元)
    • 按分銷渠道劃分的英國點膠藥市場,2015-2026年(百萬美元)
    • 意大利
    • 按應用分列的意大利點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年意大利點膠藥房市場(按點膠類型)(百萬美元)
    • 意大利無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道分列的意大利點膠藥市場,2015-2026年(百萬美元)
    • 西班牙
    • 按應用分列的西班牙點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年西班牙按配藥類型的配藥市場(百萬美元) 2015年20-2026年西班牙無菌藥品配送市場(百萬美元)
    • 按分銷渠道劃分的西班牙配藥市場(2015-2026年,百萬美元)
    • 法國
    • 按應用劃分的法國點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年按藥房類型劃分的法國藥房市場(百萬美元)
    • 2015-2026年按無菌分列的法國點膠藥市場(百萬美元)
    • 按分銷渠道劃分的法國點膠藥市場,2015-2026年(百萬美元)
    • 波蘭
    • 按應用分列的波蘭藥房市場,2015-2026年(百萬美元)
    • 2015-2026年按點膠類型劃分的點膠藥房市場(百萬美元)
    • 無菌藥水配藥市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的波蘭藥房市場,2015-2026年(百萬美元)
    • 烏克蘭
    • 烏克蘭點膠藥房應用市場,2015-2026年(百萬美元)
    • 按配藥類型劃分的烏克蘭配藥藥房市場,2015-2026年(百萬美元)
    • 烏克蘭點膠藥房市場,按無菌分列,2015-2026年(百萬美元)
    • 按分銷渠道劃分的烏克蘭點膠藥市場,2015- 2026年(百萬美元)
    • 希臘
    • 按應用分列的希臘點膠藥房市場,2015-2026年(百萬美元)
    • 希臘點膠藥房市場(按點膠類型),2015- 2026年(百萬美元)
    • 按無菌分列的希臘點膠藥房市場,2015-2026年(百萬美元)
    • 2015-2026年按分銷渠道劃分的希臘製藥市場(百萬美元)
    • 瑞典
    • 按應用分列的瑞典點膠藥市場,2015-2026年(百萬美元)
    • 瑞典點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 瑞典不丹分藥市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的瑞典點膠藥市場,2015-2026年(百萬美元)
    • 挪威
    • 按應用分列的挪威點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年按配藥類型劃分的挪威配藥市場(百萬美元)
    • 挪威無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的挪威點膠藥市場,2015-2026年(百萬美元)
    • 比利時
    • 按應用分列的比利時點膠藥市場,2015-2026年(百萬美元)
    • 比利時點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 比利時無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的比利時點膠藥市場,2015-2026年(百萬美元)
    • 捷克共和國
    • 按應用分列的捷克共和國點膠藥房市場,2015-2026年(百萬美元)
    • 2015-2026年捷克共和國按配藥類型的配藥市場(百萬美元)
    • 捷克共和國無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的捷克共和國點藥市場,2015-2026年(百萬美元)
    • 芬蘭
    • 芬蘭按需分配藥房市場,2015-2026年(百萬美元)
    • 芬蘭點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 芬蘭無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的芬蘭點膠藥市場,2015-2026年(百萬美元)
    • 俄羅斯
    • 俄羅斯腸胃外用藥市場(2015-2026年,百萬美元)
    • 按應用分列的俄羅斯點膠藥市場,2015-2026年(百萬美元)
    • 俄羅斯點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 俄羅斯點膠藥房市場,按無菌分列,2015-2026年(百萬美元)
    • 按分銷渠道劃分的俄羅斯點膠藥市場,2015-2026年(百萬美元)
  • 亞太地區
    • 2015-2026年按國家/地區劃分的亞太點膠藥市場(百萬美元)
    • 亞太點膠藥房市場,治療學,2015-2026年(百萬美元)
    • 2015-2026年亞太點膠藥房市場產品(百萬美元)
    • 按應用分列的亞太點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年亞太地區點膠藥房市場(百萬美元)
    • 按無菌分列的亞太點膠藥房市場,2015-2026年(百萬美元)
    • 2015-2026年按分銷渠道劃分的亞太點膠藥市場(百萬美元)
    • 中國
    • 按應用分列的中國點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年中國點膠藥市場(按點膠類型)(百萬美元)
    • 2015-2026年中國無菌點膠藥市場(百萬美元)
    • 按分銷渠道分列的中國點膠藥市場,2015-2026年(百萬美元)
    • 印度
    • 按應用分列的印度點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年印度點膠藥房市場分佈(百萬美元)
    • 印度無菌藥房市場,2015-2026年(百萬美元)
    • 2015-2026年印度經銷渠道的配藥市場(百萬美元)
    • 日本
    • 日本點藥市場,按應用分列,2015-2026年(百萬美元)
    • 2015-2026年日本點膠藥房市場(按點膠類型)(百萬美元)
    • 日本點膠藥房市場,無菌性,2015-2026年(百萬美元)
    • 2015-2026年按分銷渠道劃分的日本點膠藥市場(百萬美元)
    • 新加坡
    • 2015-2026年新加坡點膠藥房市場應用(百萬美元)
    • 新加坡點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 新加坡無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的新加坡點膠藥市場,2015-2026年(百萬美元)
    • 澳大利亞
    • 按應用分列的澳大利亞點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年澳大利亞按配藥類型的配藥市場(百萬美元)
    • 澳大利亞無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的澳大利亞點膠藥市場,2015-2026年(百萬美元)
  • 拉丁美洲
    • 2015-2026年按國家分列的拉丁美洲點膠藥市場(百萬美元)
    • 2015-2026年按治療領域分列的拉丁美洲點膠藥市場(百萬美元)
    • 2015-2026年拉丁美洲點膠藥市場的產品分佈(百萬美元)
    • 2015-2026年按應用分列的拉丁美洲點膠藥市場(百萬美元)
    • 2015-2026年按藥房類型劃分的拉丁美洲藥房市場(百萬美元)
    • 2015-2026年按無菌分列的拉丁美洲點膠藥市場(百萬美元)
    • 2015-2026年按分銷渠道劃分的拉丁美洲點膠藥市場(百萬美元)
    • 阿根廷
    • 巴西
    • 按應用分列的巴西點膠藥市場,2015-2026年(百萬美元)
    • 巴西點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 巴西無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的巴西點膠藥市場,2015-2026年(百萬美元)
    • 墨西哥
    • 按應用分列的墨西哥點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年墨西哥按配藥類型的配藥市場(百萬美元)
    • 墨西哥無菌藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的墨西哥點膠藥市場,2015-2026年(百萬美元)
  • 中東/非洲
    • 2015-2026年按國家分列的中東和非洲點藥市場(百萬美元)
    • 按治療領域分列的中東/非洲點膠藥市場,2015-2026年(百萬美元)
    • 中東/非洲點膠藥房市場產品分佈,2015-2026年(百萬美元)
    • 按應用分列的中東和非洲點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年按藥房類型劃分的中東和非洲藥房市場(百萬美元)
    • 中東/非洲點膠藥房市場,按無菌度分,2015-2026(百萬美元)
    • 按分銷渠道劃分的中東/非洲點膠藥市場,2015-2026年(百萬美元)
    • 南非
    • 按應用分列的南非點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年按分配類型劃分的南非配藥市場(百萬美元)
    • 2015-2026年按無菌分列的南非點膠藥市場(百萬美元)
    • 按分銷渠道劃分的南非點膠藥市場,2015-2026年(百萬美元)
    • 阿拉伯聯合酋長國
    • 按應用分列的阿聯酋點膠藥市場,2015-2026年(百萬美元)
    • 2015-2026年按配藥類型劃分的阿聯酋配藥市場(百萬美元)
    • 阿聯酋無菌藥房市場,2015-2026年(百萬美元)
    • 阿聯酋配藥市場按分銷渠道劃分,2015-2026年(百萬美元)
    • 沙特阿拉伯
    • 按應用分列的沙特阿拉伯點膠藥房市場,2015-2026年(百萬美元)
    • 沙特阿拉伯點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 無菌生產的沙特阿拉伯點膠藥房市場,2015-2026年(百萬美元)
    • 按分銷渠道劃分的沙特阿拉伯點膠藥房市場,2015-2026年(百萬美元)
    • 卡塔爾
    • 按應用分列的卡塔爾點膠藥房市場,2015-2026年(百萬美元)
    • 卡塔爾藥房市場,按混合類型分列,2015-2026年(百萬美元)
    • 卡塔爾醫藥市場,按無菌分,2015-2026(百萬美元)
    • 按分銷渠道劃分的卡塔爾點膠藥市場,2015-2026年(百萬美元)
    • 科威特
    • 科威特的配藥市場按應用分列,2015-2026年(百萬美元)
    • 科威特點膠藥房市場(按點膠類型),2015-2026年(百萬美元)
    • 科威特無菌藥房市場,2015-2026年(百萬美元)
    • 科威特的分銷市場按分銷渠道分佈的藥房市場,2015-2026年(百萬美元)

第11章公司簡介

  • Competitive Landscape
  • B. Braun Medical Inc.
  • Dougherty's Pharmacy, Inc.
  • Fagron
  • Fresenius Kabi
  • Institutional Pharmacy Solutions
  • Clinigen Group PLC
  • Lorraine's Pharmacy
  • McGuff Company Inc (McGuff Compounding Pharmacy Services)
  • Pencol Compounding Pharmacy
  • Athenex Pharma Solutions (Athenex Inc.)
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacies
  • Nephron Pharmaceuticals Corporation
  • Wedgewood Village Pharmacy, Inc.
目錄
Product Code: 749

Title:
Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral {Solid Preparations [Tablets, Capsules, Granules, Powder], Liquid Preparations [Solutions, Suspension, Emulsion, Syrup], Topical [Ointments, Creams, Gels, Pastes], Rectal [Suppositories, Enema], Parenteral [LVP, SVP]}, Nasal, Ophthalmic, Otic), By Application (Pediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility (Sterile, Non-sterile), By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.

The compounding pharmacies market is projected to record a remunerative growth rate over the coming years owing to the growing demand for customized medicine and drugs among patients to help treat a plethora of different ailments. A compounding pharmacy generally makes customized drugs and medications which are not available commercially or over the counter. These pharmacies can formulate alternative forms of drugs, drug doses, sugar-free drugs, etc.

The compounding pharmacies market is bifurcated in terms of therapeutic area, product, application, compounding type, sterility, and distribution channels.

Based on therapeutic area, the compounding pharmacies market is classified into nutritional supplements, specialty drugs, dermatology applications, pain management, hormone replacement, and others.

The nutritional supplements segment accounted for a market value of more than $580 million in 2019. Nutritional supplements are dietary supplement that is intended to provide nutrients. The examples include proteins, minerals, amino acids, vitamins, and other nutritional substances. These products are generally taken in the form of tablet, capsule or in liquid form.

With respect to product, the compounding pharmacies market is categorized into otic, ophthalmic, nasal, parenteral, rectal, topical, and oral. The nasal product segment accounted for around 8% market share in 2019. Nasal administration is a route of administration wherein drugs are insufflated through the nose.

Nasal delivery helps in addressing problems which are related to drug degradation, adverse events in the gastrointestinal tract, slow absorption, poor bioavailability, it also avoids the first-pass metabolism in the liver.

In terms of application, the compounding pharmacies market is bifurcated into veterinary, geriatric, adult, and children. The geriatric application segment is likely to record a CAGR of around 6.5% by the end of the analysis period. Surge in number of companion animals will foster the segmental growth.

Based on compounding type, the compounding pharmacies market is segmented into Pharmaceutical Dosage Alteration (PDA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Ingredient Alteration (PIA), and others.

The CUPM segment held a market value of more than $2.2 billion in 2019. Medicine shortages can occur for several reasons such as quality problems & manufacturing discontinuations as well as delays, owing to the reduced use or fallen manufacturer profits, that might be related to the launch of a new drug.

With respect to sterility, the compounding pharmacies market is divided into nonsterile dosage forms and sterile dosage form. The sterile dosage form will witness a CAGR of around 6.5% over the forecast time period. Increasing incidence of chronic diseases is expected to increase the need for sterile medications.

Based on distribution channels, the compounding pharmacies market is classified into compounding pharmacies, hospital pharmacy, and others. The others segment represented a market value of more than $850 million in 2019 and will continue to show appreciative growth in coming years.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Compounding pharmacies industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Therapeutic area trends
    • 2.1.3. Product trends
    • 2.1.4. Application trends
    • 2.1.5. Compounding type trends
    • 2.1.6. Sterility trends
    • 2.1.7. Distribution channel trends
    • 2.1.8. Regional trends

Chapter 3. Compounding Pharmacies Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry ecosystem analysis
    • 3.3.1. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
      • 3.4.1.1. Rising geriatric population and improved life expectancy across the globe
      • 3.4.1.2. Rising adoption of customized medicine in the developed regions
      • 3.4.1.3. Shortage of drugs across the globe
      • 3.4.1.4. Benefits of compounded medication
      • 3.4.1.5. Growing drug failure rate
    • 3.4.2. Industry pitfalls and challenges
      • 3.4.2.1. Lack of skilled lab technicians and pharmacists in developed economies
      • 3.4.2.2. High cost of equipment and maintenance of sterile environment
      • 3.4.2.3. Volatile regulatory scenario
      • 3.4.2.4. Consumer perception towards compounded drugs
  • 3.5. Growth potential analysis
    • 3.5.1. By therapeutic area
    • 3.5.2. By product
    • 3.5.3. By application
    • 3.5.4. By compounding type
    • 3.5.5. By sterility
    • 3.5.6. By distribution channel
  • 3.6. Regulatory landscape
    • 3.6.1. U.S.
    • 3.6.2. Europe
    • 3.6.3. Australia
  • 3.7. Reimbursement landscape
    • 3.7.1. U.S.
    • 3.7.2. Europe
    • 3.7.3. Australia
  • 3.8. Cost analysis of compounded medications
  • 3.9. Compounding pharmacies count, by region 2019
    • 3.9.1. North America
    • 3.9.2. Europe
    • 3.9.3. Asia Pacific
    • 3.9.4. Latin America
    • 3.9.5. Middle East and Africa
  • 3.10. Innovative compounding technologies
    • 3.10.1. Web-based quality management system
    • 3.10.2. Digital tools
  • 3.11. Porter's analysis
  • 3.12. PESTEL Analysis

Chapter 4. Compounding Pharmacies Market, By Therapeutic Area

  • 4.1. Key segment trends
  • 4.2. Hormone replacement
    • 4.2.1. Hormone replacement market, by region, 2015 - 2026, (USD Million)
  • 4.3. Pain management
    • 4.3.1. Pain management market, by region, 2015 - 2026, (USD Million)
  • 4.4. Dermatology
    • 4.4.1. Dermatology market, by region, 2015 - 2026, (USD Million)
  • 4.5. Specialty drugs
    • 4.5.1. Specialty drugs market, by region, 2015 - 2026, (USD Million)
  • 4.6. Nutritional supplements
    • 4.6.1. Nutritional supplements market, by region, 2015 - 2026, (USD Million)
  • 4.7. Others
    • 4.7.1. Others market, by region, 2015 - 2026, (USD Million)

Chapter 5. Compounding Pharmacies Market, By Product

  • 5.1. Key segment trends
  • 5.2. Oral
    • 5.2.1. Oral market by region, 2015 - 2026 (USD Million)
    • 5.2.2. Solid preparations
      • 5.2.2.1. Compounding pharmacies solid preparations market, by region, 2015 - 2026, (USD million)
      • 5.2.2.2. Tablets
        • 5.2.2.2.1. Compounding pharmacies tablets market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.3. Capsules
        • 5.2.2.3.1. Compounding pharmacies capsules market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.4. Granules
        • 5.2.2.4.1. Compounding pharmacies granules market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.5. Powder
        • 5.2.2.5.1. Compounding pharmacies powder market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.6. Others
        • 5.2.2.6.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
    • 5.2.3. Liquid preparations
      • 5.2.3.1. Compounding pharmacies liquid preparations market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.2. Solutions
        • 5.2.3.2.1. Compounding pharmacies solutions market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.3. Suspension
        • 5.2.3.3.1. Compounding pharmacies suspension market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.4. Emulsion
        • 5.2.3.4.1. Compounding pharmacies emulsion market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.5. Syrup
        • 5.2.3.5.1. Compounding pharmacies syrup market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.6. Others
        • 5.2.3.6.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • 5.3. Topical
    • 5.3.1. Topical market, by region, 2015 - 2026, (USD Million)
    • 5.3.2. Ointments
      • 5.3.2.1. Compounding pharmacies ointments market, by region, 2015 - 2026, (USD Million)
    • 5.3.3. Creams
      • 5.3.3.1. Compounding pharmacies creams market, by region, 2015 - 2026, (USD Million)
    • 5.3.4. Gels
      • 5.3.4.1. Compounding pharmacies gels market, by region, 2015 - 2026, (USD Million)
    • 5.3.5. Pastes
      • 5.3.5.1. Compounding pharmacies pastes market, by region, 2015 - 2026, (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • 5.4. Rectal
    • 5.4.1. Rectal market by region, 2015 - 2026 (USD Million)
    • 5.4.2. Suppositories
      • 5.4.2.1. Compounding pharmacies suppositories market, by region, 2015 - 2026, (USD Million)
    • 5.4.3. Enema
      • 5.4.3.1. Compounding pharmacies enema market, by region, 2015 - 2026, (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • 5.5. Parenteral
    • 5.5.1. Parenteral market by region, 2015 - 2026 (USD Million)
    • 5.5.2. Small volume parenteral (SVP) solutions
      • 5.5.2.1. Small volume parenteral (SVP) solutions market by region, 2015 - 2026 (USD Million)
    • 5.5.3. Large Volume Parenteral (LVP) Solutions
      • 5.5.3.1. Large Volume Parenteral (LVP) Solutions market by region, 2015 - 2026 (USD Million)
  • 5.6. Nasal
    • 5.6.1. Nasal market by region, 2015 - 2026 (USD Million)
  • 5.7. Ophthalmic
    • 5.7.1. Ophthalmic market by region, 2015 - 2026 (USD Million)
  • 5.8. Otic
    • 5.8.1. Otic market by region, 2015 - 2026 (USD Million)

Chapter 6. Compounding Pharmacies Market, By Application

  • 6.1. Key segment trends
  • 6.2. Paediatric
    • 6.2.1. Paediatric compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • 6.3. Adult
    • 6.3.1. Adult compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • 6.4. Geriatric
    • 6.4.1. Geriatric compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • 6.5. Veterinary
    • 6.5.1. Veterinary compounding pharmacies market, by region 2015 - 2026, (USD Million)

Chapter 7. Compounding Pharmacies Market, By Compounding Type

  • 7.1. Key segment trends
  • 7.2. Pharmaceutical Ingredient Alteration (PIA)
    • 7.2.1. Pharmaceutical ingredient alteration (PIA) market, by region, 2015 - 2026, (USD Million)
  • 7.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • 7.3.1. Currently unavailable pharmaceutical manufacturing (CUPM) market, by region, 2015 - 2026, (USD Million)
  • 7.4. Pharmaceutical Dosage Alteration (PDA)
    • 7.4.1. Pharmaceutical dosage alteration (PDA) market, by region, 2015 - 2026, (USD Million)
  • 7.5. Others
    • 7.5.1. Others market, by region, 2015 - 2026, (USD Million)

Chapter 8. Compounding Pharmacies Market, By Sterility

  • 8.1. Key segment trends
  • 8.2. Sterile
    • 8.2.1. Sterile compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • 8.3. Non-sterile
    • 8.3.1. Non-sterile compounding pharmacies market, by region, 2015 - 2026, (USD Million)

Chapter 9. Compounding Pharmacies Market, By Distribution Channel

  • 9.1. Key segment trends
  • 9.2. Hospital Pharmacy
    • 9.2.1. Hospital pharmacy market, by region, 2015 - 2026, (USD Million)
  • 9.3. Compounding pharmacy
    • 9.3.1. Compounding pharmacy market, by region, 2015 - 2026, (USD Million)
  • 9.4. Others
    • 9.4.1. Others market, by region, 2015 - 2026, (USD Million)

Chapter 10. Compounding Pharmacies Market, By Region

  • 10.1. Key regional trends
  • 10.2. North America
    • 10.2.1. North America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.2.2. North America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.2.3. North America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.2.3.1. North America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.2.3.1.1. North America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.2.3.1.2. North America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.2.3.2. North America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.2.3.3. North America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.2.3.4. North America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.2.4. North America compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.2.5. North America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.2.6. North America compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.2.7. North America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.2.8. U.S.
      • 10.2.8.1. U.S. compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.2.8.2. U.S. compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.2.8.2.1. U.S. compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.2.8.2.1.1. U.S. compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.2.8.2.1.2. U.S. compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.2.8.3. U.S. compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.2.8.4. U.S. compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.2.8.5. U.S. compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.2.9. U.S. compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.2.10. U.S. compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.2.11. U.S. compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.2.12. U.S. compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.2.13. Canada
      • 10.2.13.1. Canada compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.2.13.2. Canada compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.2.13.2.1. Canada compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.2.13.2.1.1. Canada compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.2.13.2.1.2. Canada compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.2.13.3. Canada compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.2.13.4. Canada compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.2.13.5. Canada compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.2.14. Canada compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.2.15. Canada compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.2.16. Canada compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.2.17. Canada compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.3. Europe
    • 10.3.1. Europe compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.3.2. Europe compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.3.3. Europe compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.3.3.1. Europe compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.3.1.1. Europe compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.3.1.2. Europe compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.3.2. Europe compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.3.3. Europe compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.3.4. Europe compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.4. Europe compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.5. Europe compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.6. Europe compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.7. Europe compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.8. Germany
      • 10.3.8.1. Germany compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.8.2. Germany compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.8.2.1. Germany compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.8.2.1.1. Germany compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.8.2.1.2. Germany compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.8.3. Germany compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.8.4. Germany compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.8.5. Germany compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.9. Germany compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.10. Germany compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.11. Germany compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.12. Germany compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.13. UK
      • 10.3.13.1. UK compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.13.2. UK compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.13.2.1. UK compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.13.2.1.1. UK compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.13.2.1.2. UK compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.13.3. UK compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.13.4. UK compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.13.5. UK compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.14. UK compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.15. UK compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.16. UK compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.17. UK compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.18. Italy
      • 10.3.18.1. Italy compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.18.2. Italy compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.18.2.1. Italy compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.18.2.2. Italy compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
      • 10.3.18.3. Italy compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.18.4. Italy compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.18.5. Italy compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.18.6. Italy compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.19. Italy compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.20. Italy compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.21. Italy compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.22. Italy compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.23. Spain
      • 10.3.23.1. Spain compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.23.2. Spain compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.23.2.1. Spain compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.23.2.2. Spain compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.23.2.3. Spain compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.23.3. Spain compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.23.4. Spain compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.23.5. Spain compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.24. Spain compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.25. Spain compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.26. Spain compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.27. Spain compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.28. France
      • 10.3.28.1. France compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.28.2. France compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.28.2.1. France compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.28.2.1.1. France compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.28.2.1.2. France compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.28.3. France compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.28.4. France compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.28.5. France compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.29. France compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.30. France compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.31. France compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.32. France compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.33. Poland
      • 10.3.33.1. Poland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.33.2. Poland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.33.2.1. Poland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.33.2.2. Poland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.33.2.3. Poland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.33.3. Poland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.33.4. Poland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.33.5. Poland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.34. Poland compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.35. Poland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.36. Poland compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.37. Poland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.38. Ukraine
      • 10.3.38.1. Ukraine compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.38.2. Ukraine compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.38.2.1. Ukraine compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.38.2.1.1. Ukraine compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.38.2.1.2. Ukraine compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.38.3. Ukraine compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.38.4. Ukraine compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.38.5. Ukraine compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.39. Ukraine compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.40. Ukraine compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.41. Ukraine compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.42. Ukraine compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.43. Greece
      • 10.3.43.1. Greece compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.43.2. Greece compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.43.2.1.1. Greece compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.43.2.1.2. Greece compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
      • 10.3.43.3. Greece compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.43.4. Greece compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.43.5. Greece compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.43.6. Greece compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.44. Greece compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.45. Greece compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.46. Greece compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.47. Greece compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.48. Sweden
      • 10.3.48.1. Sweden compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.48.2. Sweden compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.48.2.1. Sweden compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.48.2.1.1. Sweden compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.48.2.1.2. Sweden compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.48.3. Sweden compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.48.4. Sweden compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.48.5. Sweden compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.49. Sweden compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.50. Sweden compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.51. Sweden compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.52. Sweden compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.53. Norway
      • 10.3.53.1. Norway compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.53.2. Norway compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.53.2.1. Norway compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.53.2.1.1. Norway compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.53.2.1.2. Norway compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.53.3. Norway compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.53.4. Norway compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.53.5. Norway compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.54. Norway compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.55. Norway compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.56. Norway compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.57. Norway compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.58. Belgium
      • 10.3.58.1. Belgium compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.58.2. Belgium compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.58.2.1. Belgium compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.58.2.1.1. Belgium compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.58.2.1.2. Belgium compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.58.3. Belgium compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.58.4. Belgium compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.58.5. Belgium compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.59. Belgium compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.60. Belgium compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.61. Belgium compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.62. Belgium compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.63. Czech Republic
      • 10.3.63.1. Czech Republic compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.63.2. Czech Republic compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.63.2.1. Czech Republic compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.63.2.1.1. Czech Republic compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.63.2.1.2. Czech Republic compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.63.3. Czech Republic compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.63.4. Czech Republic compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.63.5. Czech Republic compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.64. Czech Republic compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.65. Czech Republic compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.66. Czech Republic compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.67. Czech Republic compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.68. Finland
      • 10.3.68.1. Finland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.68.2. Finland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.68.2.1. Finland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.68.2.1.1. Finland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.68.2.1.2. Finland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.68.3. Finland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.68.4. Finland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.68.5. Finland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.69. Finland compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.70. Finland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.71. Finland compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.72. Finland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.73. Russia
      • 10.3.73.1. Russia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.73.2. Russia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.73.2.1. Russia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.73.2.2. Russia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
      • 10.3.73.3. Russia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.73.4. Russia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.73.5. Russia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
    • 10.3.74. Russia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.75. Russia compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.76. Russia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.77. Russia compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.78. Russia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.4.2. Asia Pacific compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.4.3. Asia Pacific compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.4.3.1. Asia Pacific compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.4.3.1.1. Asia Pacific compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.4.3.1.2. Asia Pacific compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.3.2. Asia Pacific compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.3.3. Asia Pacific compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.3.4. Asia Pacific compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.4. Asia Pacific compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.5. Asia Pacific compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.6. Asia Pacific compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.7. Asia Pacific compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.8. China
      • 10.4.8.1. China compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.8.2. China compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.8.2.1. China compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.8.2.1.1. China compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.8.2.1.2. China compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.8.3. China compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.8.4. China compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.8.5. China compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.9. China compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.10. China compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.11. China compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.12. China compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.13. India
      • 10.4.13.1. India compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.13.2. India compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.13.2.1. India compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.13.2.1.1. India compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.13.2.1.2. India compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.13.3. India compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.13.4. India compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.13.5. India compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.14. India compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.15. India compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.16. India compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.17. India compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.18. Japan
      • 10.4.18.1. Japan compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.18.2. Japan compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.18.2.1. Japan compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.18.2.1.1. Japan compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.18.2.1.2. Japan compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.18.3. Japan compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.18.4. Japan compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.18.5. Japan compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.19. Japan compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.20. Japan compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.21. Japan compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.22. Japan compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.23. Singapore
      • 10.4.23.1. Singapore compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.23.2. Singapore compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.23.2.1. Singapore compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.23.2.1.1. Singapore compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.23.2.1.2. Singapore compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.23.3. Singapore compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.23.4. Singapore compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.23.5. Singapore compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.24. Singapore compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.25. Singapore compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.26. Singapore compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.27. Singapore compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.28. Australia
      • 10.4.28.1. Australia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.28.2. Australia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.28.2.1. Australia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.28.2.1.1. Australia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.28.2.1.2. Australia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.28.3. Australia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.28.4. Australia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.28.5. Australia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.29. Australia compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.30. Australia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.31. Australia compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.32. Australia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.5. Latin America
    • 10.5.1. Latin America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.5.2. Latin America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.5.3. Latin America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.5.3.1. Latin America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.5.3.1.1. Latin America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.5.3.1.2. Latin America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.3.2. Latin America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.3.3. Latin America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.3.4. Latin America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.5.4. Latin America compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.5.5. Latin America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.5.6. Latin America compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.5.7. Latin America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.5.8. Argentina
      • 10.5.8.1. Argentina compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.5.8.2. Argentina compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.5.8.2.1. Argentina compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.5.8.2.1.1. Argentina compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.5.8.2.1.2. Argentina compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.8.3. Argentina compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.8.4. Argentina compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.8.5. Argentina compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
      • 10.5.8.6. Argentina compounding pharmacies market, by application, 2015 - 2026 (USD Million)
      • 10.5.8.7. Argentina compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
      • 10.5.8.8. Argentina compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
      • 10.5.8.9. Argentina compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.5.9. Brazil
      • 10.5.9.1. Brazil compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.5.9.2. Brazil compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.5.9.2.1. Brazil compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.5.9.2.1.1. Brazil compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.5.9.2.1.2. Brazil compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.9.3. Brazil compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.9.4. Brazil compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.9.5. Brazil compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.5.10. Brazil compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.5.11. Brazil compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.5.12. Brazil compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.5.13. Brazil compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.5.14. Mexico
      • 10.5.14.1. Mexico compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.5.14.2. Mexico compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.5.14.2.1. Mexico compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.5.14.2.1.1. Mexico compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.5.14.2.1.2. Mexico compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.14.3. Mexico compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.14.4. Mexico compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.14.5. Mexico compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.5.15. Mexico compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.5.16. Mexico compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.5.17. Mexico compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.5.18. Mexico compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.6. Middle East & Africa
    • 10.6.1. Middle East & Africa compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.6.2. Middle East & Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.6.3. Middle East & Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.6.3.1. Middle East & Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.6.3.1.1. Middle East & Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.6.3.1.2. Middle East & Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.3.2. Middle East & Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.3.3. Middle East & Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.3.4. Middle East & Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.4. Middle East & Africa compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.5. Middle East & Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.6. Middle East & Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.7. Middle East & Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.8. South Africa
      • 10.6.8.1. South Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.8.2. South Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.8.2.1. South Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.8.2.1.1. South Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.8.2.1.2. South Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.8.3. South Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.8.4. South Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.8.5. South Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.9. South Africa compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.10. South Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.11. South Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.12. South Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.13. UAE
      • 10.6.13.1. UAE compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.13.2. UAE compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.13.2.1. UAE compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.13.2.1.1. UAE compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.13.2.1.2. UAE compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.13.3. UAE compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.13.4. UAE compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.13.5. UAE compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.14. UAE compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.15. UAE compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.16. UAE compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.17. UAE compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.18. Saudi Arabia
      • 10.6.18.1. Saudi Arabia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.18.2. Saudi Arabia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.18.2.1. Saudi Arabia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.18.2.1.1. Saudi Arabia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.18.2.1.2. Saudi Arabia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.18.3. Saudi Arabia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.18.4. Saudi Arabia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.18.5. Saudi Arabia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.19. Saudi Arabia compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.20. Saudi Arabia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.21. Saudi Arabia compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.22. Saudi Arabia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.23. Qatar
      • 10.6.23.1. Qatar compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.23.2. Qatar compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.23.2.1. Qatar compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.23.2.1.1. Qatar compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.23.2.1.2. Qatar compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.23.3. Qatar compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.23.4. Qatar compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.23.5. Qatar compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.24. Qatar compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.25. Qatar compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.26. Qatar compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.27. Qatar compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.28. Kuwait
      • 10.6.28.1. Kuwait compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.28.2. Kuwait compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.28.2.1. Kuwait compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.28.2.1.1. Kuwait compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.28.2.1.2. Kuwait compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.28.3. Kuwait compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.28.4. Kuwait compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.28.5. Kuwait compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.29. Kuwait compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.30. Kuwait compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.31. Kuwait compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.32. Kuwait compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)

Chapter 11. Company Profiles

  • 11.1. Competitive Landscape
    • 11.1.1. Strategy Dashboard, 2019
  • 11.2. B. Braun Medical Inc.
    • 11.2.1. Business Overview
    • 11.2.2. Financial data
    • 11.2.3. Product landscape
    • 11.2.4. Strategic outlook
    • 11.2.5. SWOT analysis
  • 11.3. Dougherty's Pharmacy, Inc.
    • 11.3.1. Business overview
    • 11.3.2. Financial data
    • 11.3.3. Product landscape
    • 11.3.4. Strategic outlook
    • 11.3.5. SWOT analysis
  • 11.4. Fagron
    • 11.4.1. Business overview
    • 11.4.2. Financial data
    • 11.4.3. Product landscape
    • 11.4.4. Strategic outlook
    • 11.4.5. SWOT analysis
  • 11.5. Fresenius Kabi
    • 11.5.1. Business overview
    • 11.5.2. Financial Data
    • 11.5.3. Product landscape
    • 11.5.4. Strategic outlook
    • 11.5.5. SWOT analysis
  • 11.6. Institutional Pharmacy Solutions
    • 11.6.1. Business overview
    • 11.6.2. Financial data
    • 11.6.3. Product landscape
    • 11.6.4. SWOT analysis
  • 11.7. Clinigen Group PLC
    • 11.7.1. Business overview
    • 11.7.2. Financial data
    • 11.7.3. Product landscape
    • 11.7.4. Strategic outlook
    • 11.7.5. SWOT analysis
  • 11.8. Lorraine's Pharmacy
    • 11.8.1. Business overview
    • 11.8.2. Financial data
    • 11.8.3. Product landscape
    • 11.8.4. SWOT analysis
  • 11.9. McGuff Company Inc (McGuff Compounding Pharmacy Services)
    • 11.9.1. Business overview
    • 11.9.2. Financial data
    • 11.9.3. Product landscape
    • 11.9.4. SWOT analysis
  • 11.10. Pencol Compounding Pharmacy
    • 11.10.1. Business overview
    • 11.10.2. Financial data
    • 11.10.3. Product landscape
    • 11.10.4. SWOT analysis
  • 11.11. Athenex Pharma Solutions (Athenex Inc.)
    • 11.11.1. Business overview
    • 11.11.2. Financial data
    • 11.11.3. Product landscape
    • 11.11.4. Strategic outlook
    • 11.11.5. SWOT analysis
  • 11.12. Rx3 Compounding Pharmacy
    • 11.12.1. Business overview
    • 11.12.2. Financial data
    • 11.12.3. Product landscape
    • 11.12.4. SWOT analysis
  • 11.13. Triangle Compounding Pharmacies
    • 11.13.1. Business overview
    • 11.13.2. Financial data
    • 11.13.3. Product landscape
    • 11.13.4. SWOT analysis
  • 11.14. Nephron Pharmaceuticals Corporation
    • 11.14.1. Business overview
    • 11.14.2. Financial data
    • 11.14.3. Product landscape
    • 11.14.4. Strategic outlook
    • 11.14.5. SWOT analysis
  • 11.15. Wedgewood Village Pharmacy, Inc.
    • 11.15.1. Business overview
    • 11.15.2. Financial data
    • 11.15.3. Product landscape
    • 11.15.4. SWOT analysis

Data Tables

  • TABLE 1. Compounding pharmacies industry 360 degree synopsis, 2015 - 2026
  • TABLE 2. Global compounding pharmacies market, 2015 - 2026 (USD Million)
  • TABLE 3. Global compounding pharmacies market, 2020 - 2026 (USD Million)
  • TABLE 4. Global compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 5. Global compounding pharmacies market, by therapeutic area, 2020 - 2026 (USD Million)
  • TABLE 6. Global compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 7. Global compounding pharmacies market, by product, 2020 - 2026 (USD Million)
  • TABLE 8. Global compounding pharmacies market, by application, 2015 - 2026 (USD Million)
  • TABLE 9. Global compounding pharmacies market, by application, 2015 - 2026 (USD Million)
  • TABLE 10. Global compounding pharmacies market, by compounding type, 2013 - 2027 (USD Million)
  • TABLE 11. Global compounding pharmacies market, by compounding type, 2020 - 2026 (USD Million)
  • TABLE 12. Global compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
  • TABLE 13. Global compounding pharmacies market, by sterility, 2020 - 2026 (USD Million)
  • TABLE 14. Global compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 15. Global compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 16. Global compounding pharmacies market, by region, 2015 - 2026 (USD Million)
  • TABLE 17. Global compounding pharmacies market, by region, 2020 - 2026 (USD Million)
  • TABLE 18. Industry impact forces
  • TABLE 19. Hormone replacement market, by region, 2015 - 2026, (USD Mn)
  • TABLE 20. Pain management market, by region, 2015 - 2026, (USD Million)
  • TABLE 21. Dermatology market, by region, 2015 - 2026, (USD Million)
  • TABLE 22. Specialty drugs market, by region, 2015 - 2026, (USD Million)
  • TABLE 23. Nutritional supplements market, by region, 2015 - 2026, (USD Million)
  • TABLE 24. Others market, by region, 2015 - 2026, (USD Million)
  • TABLE 25. Oral market by region, 2015 - 2026 (USD Million)
  • TABLE 26. Compounding pharmacies solid preparations market, by region, 2015 - 2026, (USD Mn)
  • TABLE 27. Compounding pharmacies tablets market, by region, 2015 - 2026, (USD Million)
  • TABLE 28. Compounding pharmacies market capsules market, by region, 2015 - 2026, (USD Million)
  • TABLE 29. Compounding pharmacies granules market, by region, 2015 - 2026, (USD Million)
  • TABLE 30. Compounding pharmacies powder market, by region, 2015 - 2026, (USD Million)
  • TABLE 31. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • TABLE 32. Compounding pharmacies liquid preparations market, by region, 2015 - 2026, (USD Million)
  • TABLE 33. Compounding pharmacies solutions market, by region, 2015 - 2026, (USD Million)
  • TABLE 34. Compounding pharmacies market suspension market, by region, 2015 - 2026, (USD Mn)
  • TABLE 35. Compounding pharmacies emulsion market, by region, 2015 - 2026, (USD Million)
  • TABLE 36. Compounding pharmacies syrup market, by region, 2015 - 2026, (USD Million)
  • TABLE 37. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • TABLE 38. Topical market, by region, 2015 - 2026, (USD Million)
  • TABLE 39. Compounding pharmacies ointments market, by region, 2015 - 2026, (USD Million)
  • TABLE 40. Compounding pharmacies creams market, by region, 2015 - 2026, (USD Million)
  • TABLE 41. Compounding pharmacies gels market, by region, 2015 - 2026, (USD Million)
  • TABLE 42. Compounding pharmacies pastes market, by region, 2015 - 2026, (USD Million)
  • TABLE 43. Compounding pharmacies others market, 2015 - 2026, (USD Million)
  • TABLE 44. Rectal market by region, 2015 - 2026 (USD Million)
  • TABLE 45. Compounding pharmacies suppositories market, by region, 2015 - 2026, (USD Mn)
  • TABLE 46. Compounding pharmacies enema market, by region, 2015 - 2026, (USD Million)
  • TABLE 47. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • TABLE 48. Parenteral market by region, 2015 - 2026 (USD Million)
  • TABLE 49. Small volume parenteral (SVP) solutions market by region, 2015 - 2026 (USD Million)
  • TABLE 50. Large volume parenteral (LVP) solutions market by region, 2015 - 2026 (USD Million)
  • TABLE 51. Nasal market by region, 2015 - 2026 (USD Million)
  • TABLE 52. Ophthalmic market by region, 2015 - 2026 (USD Million)
  • TABLE 53. Otic market by region, 2015 - 2026 (USD Million)
  • TABLE 54. Paediatric compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • TABLE 55. Adult compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • TABLE 56. Geriatric compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • TABLE 57. Veterinary compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • TABLE 58. Pharmaceutical ingredient alteration (PIA) market, by region, 2015 - 2026, (USD Mn)
  • TABLE 59. Currently unavailable pharmaceutical manufacturing (CUPM) market, by region, 2015 - 2026, (USD Million)
  • TABLE 60. Pharmaceutical dosage alteration (PDA) market, by region, 2015 - 2026, (USD Mn)
  • TABLE 61. Others market, by region, 2015 - 2026, (USD Mn)
  • TABLE 62. Sterile compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • TABLE 63. Non-sterile compounding pharmacies market, by region, 2015 - 2026, (USD Mn)
  • TABLE 64. Hospital pharmacy market, by region, 2015 - 2026, (USD Mn)
  • TABLE 65. Compounding pharmacy market, by region, 2015 - 2026, (USD Mn)
  • TABLE 66. Others market, by region, 2015 - 2026, (USD Million)
  • TABLE 67. North America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 68. North America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 69. North America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 70. North America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 71. North America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 72. North America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 73. North America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 74. North America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 75. North America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 76. North America compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 77. North America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 78. North America compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 79. North America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 80. U.S. compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 81. U.S. compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 82. U.S. compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 83. U.S. compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 84. U.S. compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 85. U.S. compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 86. U.S. compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 87. U.S. compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 88. U.S. compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 89. U.S. compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 90. U.S. compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 91. U.S. compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 92. Canada compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 93. Canada compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 94. Canada compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 95. Canada compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 96. Canada compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 97. Canada compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 98. Canada compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 99. Canada compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 100. Canada compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 101. Canada compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 102. Canada compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 103. Canada compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 104. Europe compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 105. Europe compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 106. Europe compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 107. Europe compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 108. Europe compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 109. Europe compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 110. Europe compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 111. Europe compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 112. Europe compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 113. Europe compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 114. Europe compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 115. Europe compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 116. Europe compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 117. Germany compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 118. Germany compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 119. Germany compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 120. Germany compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 121. Germany compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 122. Germany compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 123. Germany compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 124. Germany compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 125. Germany compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 126. Germany compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 127. Germany compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 128. Germany compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 129. UK compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 130. UK compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 131. UK compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 132. UK compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 133. UK compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 134. UK compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 135. UK compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 136. UK compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 137. UK compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 138. UK compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 139. UK compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 140. UK compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 141. Italy compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 142. Italy compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 143. Italy compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 144. Italy compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 145. Italy compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 146. Italy compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 147. Italy compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 148. Italy compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 149. Italy compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 150. Italy compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 151. Italy compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 152. Italy compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 153. Spain compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 154. Spain compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 155. Spain compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 156. Spain compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 157. Spain compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 158. Spain compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 159. Spain compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 160. Spain compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 161. Spain compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 162. Spain compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 163. Spain compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 164. Spain compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 165. France compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 166. France compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 167. France compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 168. France compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 169. France compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 170. France compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 171. France compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 172. France compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 173. France compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 174. France compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 175. France compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 176. France compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 177. Poland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 178. Poland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 179. Poland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 180. Poland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 181. Poland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 182. Poland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 183. Poland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 184. Poland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 185. Poland compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 186. Poland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 187. Poland compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 188. Poland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 189. Ukraine compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 190. Ukraine compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 191. Ukraine compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 192. Ukraine compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 193. Ukraine compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 194. Ukraine compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 195. Ukraine compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 196. Ukraine compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 197. Ukraine compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 198. Ukraine compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 199. Ukraine compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 200. Ukraine compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 201. Greece compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 202. Greece compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 203. Greece compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 204. Greece compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 205. Greece compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 206. Greece compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 207. Greece compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 208. Greece compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 209. Greece compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 210. Greece compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 211. Greece compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 212. Greece compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 213. Sweden compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 214. Sweden compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 215. Sweden compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 216. Sweden compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 217. Sweden compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 218. Sweden compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 219. Sweden compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 220. Sweden compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 221. Sweden compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 222. Sweden compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 223. Sweden compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 224. Sweden compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 225. Norway compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 226. Norway compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 227. Norway compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 228. Norway compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 229. Norway compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 230. Norway compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 231. Norway compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 232. Norway compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 233. Norway compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 234. Norway compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 235. Norway compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 236. Norway compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 237. Belgium compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 238. Belgium compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 239. Belgium compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 240. Belgium compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 241. Belgium compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 242. Belgium compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 243. Belgium compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 244. Belgium compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 245. Belgium compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 246. Belgium compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 247. Belgium compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 248. Belgium compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 249. Czech Republic compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 250. Czech Republic compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 251. Czech Republic compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 252. Czech Republic compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 253. Czech Republic compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 254. Czech Republic compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 255. Czech Republic compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 256. Czech Republic compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 257. Czech Republic compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 258. Czech Republic compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 259. Czech Republic compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 260. Czech Republic compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 261. Finland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 262. Finland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 263. Finland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 264. Finland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 265. Finland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 266. Finland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 267. Finland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 268. Finland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 269. Finland compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 270. Finland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 271. Finland compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 272. Finland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 273. Russia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 274. Russia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 275. Russia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 276. Russia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 277. Russia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 278. Russia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 279. Russia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 280. Russia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 281. Russia compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 282. Russia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 283. Russia compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 284. Russia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 285. Asia Pacific compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 286. Asia Pacific compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 287. Asia Pacific compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 288. Asia Pacific compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 289. Asia Pacific compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 290. Asia Pacific compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 291. Asia Pacific compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 292. Asia Pacific compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 293. Asia Pacific compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 294. Asia Pacific compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 295. Asia Pacific compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 296. Asia Pacific compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 297. Asia Pacific compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 298. China compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 299. China compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 300. China compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 301. China compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 302. China compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 303. China compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 304. China compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 305. China compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 306. China compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 307. China compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 308. China compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 309. China compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 310. India compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 311. India compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 312. India compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 313. India compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 314. India compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 315. India compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 316. India compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 317. India compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 318. India compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 319. India compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 320. India compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 321. India compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 322. Japan compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 323. Japan compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 324. Japan compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 325. Japan compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 326. Japan compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 327. Japan compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 328. Japan compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 329. Japan compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 330. Japan compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 331. Japan compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 332. Japan compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 333. Japan compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 334. Singapore compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 335. Singapore compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 336. Singapore compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 337. Singapore compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 338. Singapore compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 339. Singapore compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 340. Singapore compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 341. Singapore compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 342. Singapore compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 343. Singapore compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 344. Singapore compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 345. Singapore compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 346. Australia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 347. Australia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 348. Australia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 349. Australia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 350. Australia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 351. Australia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 352. Australia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 353. Australia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 354. Australia compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 355. Australia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 356. Australia compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 357. Australia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 358. Latin America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 359. Latin America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 360. Latin America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 361. Latin America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 362. Latin America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 363. Latin America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 364. Latin America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 365. Latin America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 366. Latin America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 367. Latin America compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 368. Latin America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 369. Latin America compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 370. Latin America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 371. Argentina compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 372. Argentina compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 373. Argentina compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 374. Argentina compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 375. Argentina compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 376. Argentina compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 377. Argentina compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 378. Argentina compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 379. Argentina compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 380. Argentina compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 381. Argentina compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 382. Argentina compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 383. Brazil compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 384. Brazil compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 385. Brazil compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 386. Brazil compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 387. Brazil compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 388. Brazil compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 389. Brazil compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 390. Brazil compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 391. Brazil compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 392. Brazil compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 393. Brazil compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 394. Brazil compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 395. Mexico compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 396. Mexico compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 397. Mexico compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 398. Mexico compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 399. Mexico compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 400. Mexico compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 401. Mexico compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 402. Mexico compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 403. Mexico compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 404. Mexico compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 405. Mexico compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 406. Mexico compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 407. Middle East & Africa compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 408. Middle East & Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 409. Middle East & Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 410. Middle East & Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 411. Middle East & Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 412. Middle East & Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 413. Middle East & Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 414. Middle East & Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 415. Middle East & Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 416. Middle East & Africa compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 417. Middle East & Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 418. Middle East & Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 419. Middle East & Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 420. South Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 421. South Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 422. South Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 423. South Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 424. South Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 425. South Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 426. South Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 427. South Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 428. South Africa compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 429. South Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 430. South Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 431. South Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 432. UAE compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 433. UAE compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 434. UAE compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 435. UAE compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 436. UAE compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 437. UAE compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 438. UAE compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 439. UAE compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 440. UAE compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 441. UAE compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 442. UAE compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 443. UAE compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 444. Saudi Arabia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 445. Saudi Arabia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 446. Saudi Arabia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 447. Saudi Arabia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 448. Saudi Arabia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 449. Saudi Arabia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 450. Saudi Arabia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 451. Saudi Arabia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 452. Saudi Arabia compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 453. Saudi Arabia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 454. Saudi Arabia compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 455. Saudi Arabia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 456. Qatar compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 457. Qatar compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 458. Qatar compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 459. Qatar compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 460. Qatar compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 461. Qatar compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 462. Qatar compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 463. Qatar compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 464. Qatar compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 465. Qatar compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 466. Qatar compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 467. Qatar compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 468. Kuwait compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 469. Kuwait compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 470. Kuwait compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 471. Kuwait compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 472. Kuwait compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 473. Kuwait compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 474. Kuwait compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 475. Kuwait compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 476. Kuwait compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 477. Kuwait compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 478. Kuwait compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 479. Kuwait compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global compounding pharmacies market, 2015 - 2026 (USD Million)
  • FIG. 3 Industry ecosystem analysis
  • FIG. 4 Distribution channel analysis
  • FIG. 5 Growth potential analysis, by therapeutic area
  • FIG. 6 Growth potential analysis, by product
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by compounding type
  • FIG. 9 Growth potential analysis, by sterility
  • FIG. 10 Growth potential analysis, by distribution channel
  • FIG. 11 Porter's Analysis
  • FIG. 12 PESTEL Analysis
  • FIG. 13 Key segment trends
  • FIG. 14 Key segment trends
  • FIG. 15 Key segment trends
  • FIG. 16 Key segment trends
  • FIG. 17 Key segment trends
  • FIG. 18 Key segment trends
  • FIG. 19 Key regional trends
  • FIG. 20 Strategy Dashboard